drugset / Trial / NCT04662242

The Prognostic Impact of Selenium On Critical Surgical Patients

NCT04662242 ↗

Phase 4 Completed 36 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Selenium is an important trace element for human for its multiple roles such as the antioxidant activity. Previous evidences showed that critically ill patients may benefit from selenium supplement but the dose and results are controversial. Patients after operations for acute abdomen usually suffer from sepsis and stress. The aim of this study is to investigate the efficacy of selenium replacement in critical patients of acute abdomen, to see the impact on prognosis.

Timeline

Start
2020-12-01
Primary completion
2022-10-31
Completion
2022-11-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Selenium Supplement Unknown 400 ug Intravenous